Skip to main content
. 2022 Apr 7;23(8):4076. doi: 10.3390/ijms23084076

Table 1.

Number of variants in J proteins, otherwise referred to as Hsp40s, previously associated with neurological phenotypes and/or phenotypes presenting with neurological features.

Gene Disease ClinVar Pathogenic ClinVar Likely Pathogenic
Missense LoF Missense LoF
DNAJA3 Developmental delay and polyneuropathy NA NA NA NA
DNAJB2 Charcot–Marie–Tooth disease; distal spinal muscular atrophy NA 7 2 4
DNAJB5 Peripheral neuropathy; skeletal myopathy; peripheral neuropathy NA NA 1 NA
DNAJB6 Limb–girdle muscular dystrophy, type 1E; frontotemporal dementia 8 1 4 NA
DNAJC3 Combined cerebellar and peripheral ataxia with hearing loss and diabetes mellitus NA 3 NA 1
DNAJC5 Neuronal ceroid lipofuscinosis 1 2 NA NA
DNAJC6 Juvenile-onset Parkinson’s disease 19a 2 9 NA NA
DNAJC7 Amyotrophic lateral sclerosis NA NA NA NA
DNAJC12 Mild hyperphenylalaninemia, non-bh4-deficient; early-onset parkinsonism 2 10 NA 2
DNAJC13 Late-onset Parkinson’s disease; essential tremor 1 NA NA NA
DNAJC16 Hereditary spastic paraplegia NA NA NA NA
DNAJC19 3-Methylglutaconic aciduria type V NA 4 1 2
DNAJC21 Bone marrow failure syndrome 3; tongue abnormality, acute myeloid leukemia, cognitive impairment, pancytopenia, pectus excavatum, short stature, and webbed neck 2 8 NA NA
DNAJC28 Delayed speech and language, generalized hypotonia, intellectual disability, seizures, and optic atrophy NA NA NA NA
DNAJC30 Leber hereditary optic neuropathy 3 NA 1 NA
GAK Parkinson’s disease NA NA NA NA
SACS Spastic ataxia of Charlevoix–Saguenay; Spastic paraplegia 18 155 17 188

Previous disease associations were based on reports of variant pathogenicity in the ClinVar database. NA: no variants were reported with the pathogenicity classification in ClinVar; LoF: putative loss-of-function variants, including essential splice site, frameshift, stop gain, and stop loss variants.